Top Story
September 20, 2018
Read the
Perspective
from
Darrell Gray, II, MD, MPH
The implementation of an organized screening program of annual fecal immunochemical tests combined with colonoscopy demonstrated a significant, and rapid, increase of colorectal cancer screening participation, according to results of a dynamic cohort of health plan members at an institution.
The results also demonstrated that as colorectal screening participation increased over a 15-year period, cancer mortality decreased more than 50% during that time.
In the Journals
September 19, 2018
Valsartan products that were contaminated with N-nitrosodimethylamine, an impurity that has been classified as a probable human carcinogen that led to recalls of several…
In the Journals
September 17, 2018
At the conventional fecal immunochemical test positivity threshold, programmatic sensitivity for detection of colorectal cancer decreased as age increased and was higher…
In the Journals Plus
September 17, 2018
The anti-inflammatory and anti-neoplastic agent taurolidine significantly decreased IL-6 levels in patients undergoing colon cancer surgery, potentially improving…